eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 10/05/2012
PIL Climagest 1mg, film coated tablet, 2mg, film coated tablet

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
Updated on 24/02/2012 and displayed until 10/05/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 21/10/2009 and displayed until 24/02/2012
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 13/05/2009 and displayed until 21/10/2009
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 26/09/2008 and displayed until 13/05/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 18/04/2008 and displayed until 26/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 31/01/2007 and displayed until 18/04/2008
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 18/03/2005 and displayed until 31/01/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 03/03/2004 and displayed until 18/03/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 05/06/2003 and displayed until 03/03/2004
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/06/2002 and displayed until 05/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 21/06/2002 and displayed until 24/06/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 12/11/2001 and displayed until 21/06/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 21/05/2001 and displayed until 12/11/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   norethisterone
   estradiol valerate